PEN (Penumbra, Inc.) Stock Analysis - Analyst Ratings

Penumbra, Inc. (PEN) is a publicly traded Healthcare sector company. As of May 20, 2026, PEN trades at $327.39 with a market cap of $12.84B and a P/E ratio of 74.72. PEN moved +0.24% today. Year to date, PEN is +3.93%; over the trailing twelve months it is +16.45%. Its 52-week range spans $186.97 to $362.41. Analyst consensus is neutral with an average price target of $353.00. Rallies surfaces PEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate PEN?

5 analysts cover PEN: 0 strong buy, 1 buy, 4 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $353.00.

PEN Key Metrics

Key financial metrics for PEN
MetricValue
Price$327.39
Market Cap$12.84B
P/E Ratio74.72
EPS$4.38
Dividend Yield0.00%
52-Week High$362.41
52-Week Low$186.97
Volume367.59K
Avg Volume0
Revenue (TTM)$1.45B
Net Income$171.05M
Gross Margin67.39%

PEN Analyst Consensus

5 analysts cover PEN: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $353.00.

Latest PEN News

Recent PEN Insider Trades

  • Grewal Harpreet sold 100 (~$32.82K) on Apr 2, 2026.
  • Yuen Maggie sold 2.43K (~$832.47K) on Mar 2, 2026.
  • Grewal Harpreet sold 186 (~$58.15K) on Jan 6, 2026.

Common questions about PEN

What do analysts rate PEN?
5 analysts cover PEN: 0 strong buy, 1 buy, 4 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $353.00.
Does Rallies show PEN price targets?
Yes. Rallies tracks PEN analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is PEN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PEN. It does not provide personalized investment advice.
PEN

PEN